The MISS study, funded by the Ministry of Health, is a research promoted and coordinated by the Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRCCS in which some screening centers of the Emilia-Romagna, Piedmont and Tuscany regions participate.

The main objective of the study is to to evaluate whether a two-year screening interval is as effective as a one-year interval in the early detection of breast cancer in women aged 6 to 10 years. aged between 45 and 49.

The MISS study is open to women aged 45 or 46 who are residents of the areas where the study takes place and who are invited to undergo a screening mammogram. Pregnant women, women who have had breast cancer or who have a very high hereditary risk for breast cancer cannot participate.

The decision to participate is a matter of course. completely free and voluntary, and it is It is possible to withdraw from the research at any time, without any penalty. or loss of benefits, returning to the regular course of "Prevenzione Serena" screening regional programme.

In Piedmont, the adhering Centers are those indicated below:

  • ASL City of Turin, at the Senology Department of the San Giovanni Antica Sede Hospital (SGAS);
  • ASL TO3 Senology
  • ASL TO4 Senology;
  • ASL Alessandria Senology.

To learn more about the MISS studio